- Working paper
Working paper : Longevity Risk: To Bear or to Insure?
Monday 27 March 2017
Longevity Risk: To Bear or to Insure?
We compare two longevity risk management contracts in retirement: a collective arrangement that distributes the risk among participants, and a market-provided annuity contract. We evaluate the contracts’ appeal with respect to the retiree’s welfare, and the viability of the market solution through the financial reward to the annuity provider’s equity holders. The collective agreement yields marginally higher individual welfare than an annuity contract priced at its best estimate, and the annuity provider is incapable of adequately compensating its equity holders for bearing longevity risk. Therefore, market-provided annuity contracts would not co-exist with collective schemes.
Lessons learned from the Q1 2017 earnings season
As the earnings season comes to a close, the time has come to report back on what we have found.
Biosimilars – Now a reality even for complex biologics
Within the next five years, Biosimilars should take an increasingly important role as a powerful force driving down the cost of healthcare in the US and elsewhere or enabling more patients to gain access to some of the most complex biologics: eight therapies among the world’s Top 10 could face biosimilar competition, mostly in the field of inflammation.
This section develops our central scenario and our main convictions. It highlights the main orientations of our asset allocation and presents the strategies that characterize the structure of our portfolios:bond portfolios, equity portfolios and diversified portfolios.